-
RISK FACTORS FOR HEARING LOSS IN PATIENTS TREATED WITH INTENSITY-MODULATED RADIOTHERAPY FOR HEAD-AND-NECK TUMORS
Zuur, C. L., Simis, Y. J., Lamers, E. A., Hart, A. A., Dreschler, W. A., Balm, A. J. & Rasch, C. R., 2009, In: International journal of radiation oncology, biology, physics. 74, 2, p. 490-496Research output: Contribution to journal › Article › Academic › peer-review
-
Relationship between cisplatin administration and the development of ototoxicity
Rademaker-Lakhai, J. M., Crul, M., Zuur, L., Baas, P., Beijnen, J. H., Simis, Y. J. W., Van Zandwijk, N. & Schellens, J. H. M., 20 Feb 2006, In: Journal of clinical oncology. 24, 6, p. 918-924 7 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
